BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Degirmenci M, Erdogan AP, Bulut G, Atmaca H, Uzunoglu S, Karaca B, Karabulut B, Uslu R. Octreotide in combination with AT-101 induces cytotoxicity and apoptosis through up-regulation of somatostatin receptors 2 and 5 in DU-145 prostate cancer cells. Tumour Biol 2016;37:4939-44. [PMID: 26531719 DOI: 10.1007/s13277-015-4331-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Wang X, Chen Q, Wang X, Li W, Yu G, Zhu Z, Zhang W. ZEB1 activated-VPS9D1-AS1 promotes the tumorigenesis and progression of prostate cancer by sponging miR-4739 to upregulate MEF2D. Biomed Pharmacother 2020;122:109557. [PMID: 31918265 DOI: 10.1016/j.biopha.2019.109557] [Cited by in Crossref: 9] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
2 Adant S, Shah GM, Beauregard J. Combination treatments to enhance peptide receptor radionuclide therapy of neuroendocrine tumours. Eur J Nucl Med Mol Imaging 2020;47:907-21. [DOI: 10.1007/s00259-019-04499-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
3 Wu XL, Zhang JW, Li BS, Peng SS, Yuan YQ. The prognostic value of abnormally expressed lncRNAs in prostatic carcinoma: A systematic review and meta-analysis. Medicine (Baltimore) 2017;96:e9279. [PMID: 29390487 DOI: 10.1097/MD.0000000000009279] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
4 Pedraza-Arévalo S, Hormaechea-Agulla D, Gómez-Gómez E, Requena MJ, Selth LA, Gahete MD, Castaño JP, Luque RM. Somatostatin receptor subtype 1 as a potential diagnostic marker and therapeutic target in prostate cancer. Prostate 2017;77:1499-511. [PMID: 28905400 DOI: 10.1002/pros.23426] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
5 Sun H, Zou S, Candiotti KA, Peng Y, Zhang Q, Xiao W, Wen Y, Wu J, Yang J. Octreotide Attenuates Acute Kidney Injury after Hepatic Ischemia and Reperfusion by Enhancing Autophagy. Sci Rep 2017;7:42701. [PMID: 28205545 DOI: 10.1038/srep42701] [Cited by in Crossref: 17] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
6 Xu S, Yi XM, Tang CP, Ge JP, Zhang ZY, Zhou WQ. Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma. Oncol Rep 2016;36:10-22. [PMID: 27176634 DOI: 10.3892/or.2016.4791] [Cited by in Crossref: 57] [Cited by in F6Publishing: 64] [Article Influence: 9.5] [Reference Citation Analysis]